Perspectives on refractory ceramic fiber (RCF) carcinogenicity: comparisons with other fibers

Abstract In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic n...

Full description

Saved in:
Bibliographic Details
Published inInhalation toxicology Vol. 26; no. 13; pp. 789 - 810
Main Authors Greim, Helmut, Utell, Mark J., Maxim, L. Daniel, Niebo, Ron
Format Journal Article
LanguageEnglish
Published England Informa Healthcare USA, Inc 01.11.2014
Taylor & Francis
Subjects
Online AccessGet full text
ISSN0895-8378
1091-7691
1091-7691
DOI10.3109/08958378.2014.953276

Cover

Loading…
Abstract Abstract In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC (2002) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers.
AbstractList Abstract In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC (2002) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers.
In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC (2002) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers.In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC (2002) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers.
In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC ( ) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers.
In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC ( 2002 ) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers.
In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant manifestation of RCF toxicity. Intrapleural and intraperitoneal implantation induced mesotheliomas and sarcomas in laboratory animals. Chronic nose-only inhalation bioassays indicated that RCF exposure in rats increased the incidence of lung cancer and similar exposures resulted in mesothelioma in hamsters, but these studies may have been compromised by overload. Epidemiological studies in the US and Europe showed an association between exposure and prevalence of respiratory symptoms and pleural plaques, but no interstitial fibrosis, mesotheliomas, or increased numbers of lung tumors were observed. As the latency of asbestos induced mesotheliomas can be up to 50 years, the relationship between RCF exposure and respiratory malignances has not been fully determined. Nonetheless, it is possible to offer useful perspectives. RCF and rock wool have similar airborne fiber dimensions and biopersistence. Therefore, it is likely that these fibers have similar toxicology. Traditional rock wool has been the subject of numerous cohort and case control studies. For rock wool, IARC (2002) concluded that the epidemiological studies did not provide evidence of carcinogenicity. Based on analogies with rock wool (read across), it is reasonable to believe that increases in lung cancer or any mesotheliomas are unlikely to be found in the RCF-exposed cohort. RCF producers have developed a product stewardship program to measure and control fiber concentrations and to further understand the health status of their workers.
Author Maxim, L. Daniel
Utell, Mark J.
Greim, Helmut
Niebo, Ron
Author_xml – sequence: 1
  givenname: Helmut
  surname: Greim
  fullname: Greim, Helmut
  email: postsf@aol.com, postsf@aol.com
  organization: Institute of Molecular Pharmacology and Toxicology, Technical University
– sequence: 2
  givenname: Mark J.
  surname: Utell
  fullname: Utell, Mark J.
  email: postsf@aol.com, postsf@aol.com
  organization: Department of Medicine and Environmental Medicine, University of Rochester School of Medicine and Dentistry
– sequence: 3
  givenname: L. Daniel
  surname: Maxim
  fullname: Maxim, L. Daniel
  email: postsf@aol.com, postsf@aol.com
  organization: Everest Consulting Associates
– sequence: 4
  givenname: Ron
  surname: Niebo
  fullname: Niebo, Ron
  email: postsf@aol.com, postsf@aol.com
  organization: Everest Consulting Associates
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25264933$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAURi1URKeFN0DIy7LI4N8k7qIVGlFAqgRCsESWx7lpXCX2YHtazdvjMG1FWZSVF_d837XuOUIHPnhA6DUlS06JekdaJVvetEtGqFgqyVlTP0OLMqJVUyt6gBYzUs3MITpK6ZoQUhPevECHTLJaKM4X6OdXiGkDNrsbSDh4HKGPxuYQd9hCNJOzuHdriPjk2-riLbYmWufDFXhnXd6dYhumjYkuBZ_wrcsDDnko9J9Meome92ZM8OruPUY_Lj58X32qLr98_Lx6f1lZSVWuDGOdVb3qWKdYrVSnRCsZM1RaYSQjhvC2axjnUK-bWnZgFSe0bXtDAdRa8mN0tu_dbNcTdBZ8jmbUm-gmE3c6GKcfT7wb9FW40YIJSRtRCk7uCmL4tYWU9eSShXE0HsI2aVozQhgXDSnom793PSy5v2kBxB6wMaRU7vmAUKJndfpenZ7V6b26Ejv9J1YObLIL84_d-L_w-T7sfB_iZG5DHDudzW4Msfj01qU5_WTD2aOGAcyYh6Ib9HXYRl_0Pf2F327Rxlc
CitedBy_id crossref_primary_10_1016_j_taap_2018_06_011
crossref_primary_10_1007_s00210_024_03315_0
crossref_primary_10_1016_j_yrtph_2015_07_029
crossref_primary_10_1080_10937404_2016_1193361
crossref_primary_10_1007_s10973_016_5367_0
crossref_primary_10_1039_D3EN00041A
crossref_primary_10_3390_cancers12113384
crossref_primary_10_3109_08958378_2015_1051640
crossref_primary_10_1080_08958378_2017_1394931
crossref_primary_10_1080_08958378_2023_2167023
crossref_primary_10_1177_0748233719851699
crossref_primary_10_3390_ijerph15010042
crossref_primary_10_1080_08958378_2018_1448019
crossref_primary_10_1039_C6CS00895J
crossref_primary_10_1007_s13530_015_0235_z
crossref_primary_10_1134_S1087659619030039
crossref_primary_10_1080_10408444_2019_1568385
crossref_primary_10_1016_j_ceramint_2024_05_277
Cites_doi 10.1136/oem.58.12.800
10.5271/sjweh.427
10.1136/oem.52.2.105
10.1080/08958370050198511
10.1002/ajim.4700220205
10.1093/jnci/58.3.587
10.2307/3428305
10.1186/1743-8977-2-8
10.1080/10408440802273156
10.2307/3432074
10.1289/ehp.94102s5133
10.1136/thx.52.6.507
10.1164/ajrccm-conference.2011.183.1_MeetingAbstracts.A4812
10.1006/rtph.1997.1153
10.1093/occmed/kqg051
10.1053/sonc.2002.30227
10.1164/ajrccm.157.4.9707131
10.1136/bmj.e8376
10.3109/08958379509015210
10.3109/08958379509015209
10.1016/j.rmr.2011.04.008
10.1136/thx.51.Suppl_2.S9
10.1006/rtph.2000.1409
10.3109/08958379409003042
10.1080/08958370701866040
10.1093/annhyg/26.5.569
10.1016/j.yrtph.2006.04.008
10.1016/0013-9351(82)90137-2
10.1002/ajim.20844
10.1002/ajim.20316
10.1378/chest.122.6.2224
10.1006/rtph.2001.1474
10.1080/08958370701821375
10.1093/toxsci/kfs171
10.1289/ehp.97105s51261
10.1080/08958370490505016
10.1378/chest.105.1.8
10.1023/A:1008239116237
10.1111/j.1349-7006.2011.02165.x
10.1016/S0940-2993(96)80084-4
10.1006/faat.1996.0017
10.1002/ajim.10263
10.1093/annhyg/27.2.157
10.1164/rccm.201210-1911OC
10.1289/ehp.9088311
10.1136/oem.52.2.97
10.1097/JOM.0b013e3181b68cef
10.1378/chest.121.6.2044
10.5271/sjweh.1957
10.1177/030089160709300104
10.1093/oxfordjournals.aje.a009717
10.1136/oem.2006.027748
10.1016/j.ajpath.2011.02.040
10.1097/00001648-199705000-00006
10.1056/NEJM196503182721104
10.1080/10408440701524592
10.1136/oem.2009.048033
10.5271/sjweh.49
10.1136/thorax.55.10.860
10.1007/BF00381385
10.1097/00001648-200207000-00013
10.1006/rtph.2000.1443
10.3892/mco.2013.197
10.5271/sjweh.2244
10.1080/089583700196103
10.1038/bjc.2013.514
10.2486/indhealth.MS1147
10.1006/taap.1998.8472
10.1177/1420326X9700600206
10.1111/j.1539-6924.1995.tb00312.x
10.1016/j.mrfmmm.2004.06.011
10.1097/01.jom.0000052968.43131.b5
10.3109/08958379609052913
10.2486/indhealth.39.161
10.1136/oem.2004.018531
10.1081/DCT-100100112
10.1080/089583799197203
10.1378/chest.105.1.144
10.1136/oem.57.7.488
10.1007/PL00014628
10.5694/mja11.10125
10.5271/sjweh.1145
10.1097/00043764-199107000-00008
10.5094/APR.2012.020
10.1023/A:1008871718323
10.1164/ajrccm.154.5.8912756
10.1165/rcmb.2009-0206TR
10.1183/09031936.96.09061206
10.1186/1746-1596-5-81
10.1016/j.yrtph.2011.02.009
10.1016/j.rmr.2012.02.012
10.1006/rtph.2001.1513
10.1002/ajim.20394
10.3109/10408444.2014.899558
10.1016/j.ejca.2007.09.018
10.5271/sjweh.1938
10.1093/annhyg/mef034
10.1016/S0003-4878(99)00018-6
10.2486/indhealth.39.65
10.4103/0019-5278.55124
10.2486/indhealth.39.183
10.1016/0013-9351(76)90009-8
10.1080/15298669391354612
10.4103/0019-5278.111753
10.1183/09031936.95.08122149
10.1097/JOM.0b013e31818345bb
10.1080/02786828608959100
10.1006/faat.1996.0031
10.5271/sjweh.2326
10.1016/S0003-4878(98)00026-X
10.1016/j.rmed.2005.04.017
10.3109/08958370903521224
10.1093/annhyg/41.inhaled_particles_VIII.224
10.1080/089583701752378142
10.1080/08958370390248888
10.1007/BF00385650
10.3109/08958379509015208
10.1080/089583701316941294
10.1136/oem.2007.035584
10.1164/rccm.201304-0655LE
10.1056/NEJMra050152
10.1007/s004200100240
10.1016/j.yrtph.2006.05.003
10.1136/oem.2003.010165
10.2486/indhealth.45.379
10.1002/1097-0142(19900315)65:6<1449::AID-CNCR2820650633>3.0.CO;2-0
10.1080/0002889758507347
10.1002/ijc.20820
10.1016/S0232-1513(87)80044-0
10.1080/104732299302189
10.1097/JOM.0b013e31825296fd
10.1183/09031936.93.05030281
10.1016/S0140-6736(79)92468-1
10.1080/15428119591016494
10.1007/s00204-010-0580-2
10.3109/08958378.2012.683892
10.1016/S0140-6736(05)73126-3
10.1080/089583701752378133
10.1097/00043764-199007000-00009
10.1093/annhyg/31.4B.731
10.1093/annhyg/28.3.333
ContentType Journal Article
Copyright 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted 2014
2014 The Author(s). Published by Taylor & Francis. 2014
Copyright_xml – notice: 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted 2014
– notice: 2014 The Author(s). Published by Taylor & Francis. 2014
DBID 0YH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.3109/08958378.2014.953276
DatabaseName Taylor & Francis Open Access Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 0YH
  name: Taylor & Francis Open Access
  url: https://www.tandfonline.com
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Pharmacy, Therapeutics, & Pharmacology
EISSN 1091-7691
EndPage 810
ExternalDocumentID PMC4245174
25264933
10_3109_08958378_2014_953276
953276
Genre Review Article
Comparative Study
Review
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
00X
03L
08R
0BK
0R~
0VX
29I
36B
4.4
53G
5GY
5VS
AACCU
AAJNR
AALIY
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
ABBKH
ABCRQ
ABDBF
ABEIZ
ABLKL
ABPTK
ABUPF
ACENM
ACFUF
ACGEJ
ACGFO
ACGFS
ACLSK
ADCVX
ADFCX
ADRBQ
ADXPE
AECIN
AEGXH
AENEX
AEOZL
AEYQI
AFAUU
AFKVX
AFQCT
AFWLO
AGAFX
AGDLA
AGFJD
AGRBW
AGYJP
AIAGR
AIJEM
AIRBT
AJEBJ
AJWEG
AJXHO
AKBVH
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AWYRJ
BABNJ
BLEHA
BOHLJ
BVLLS
CAG
CCCUG
COF
CS3
DEIEU
DKSSO
DLVIE
DTRLO
DU5
DZHFC
EAP
EAS
EBC
EBD
EBS
EBX
EHN
EJD
EMB
EMK
EMOBN
EPL
EPT
ESX
F3I
F5P
H13
HZ~
J.N
JFOCU
KRBQP
KWAYT
KYCEM
LJTGL
M44
M4Z
O9-
P2P
QRXOQ
Q~Q
RNANH
RVRKI
SV3
TFDNU
TFL
TFW
TUS
UHWXJ
V1S
ZE2
~1N
0YH
ABJNI
ABLIJ
ABXYU
ACIEZ
ACUHS
ALYBC
TBQAZ
TERGH
TUROJ
AAGDL
AAYXX
ABWVI
ADYSH
AFRVT
AMPGV
CITATION
ACKYO
AOYHP
CGR
CUY
CVF
ECM
EIF
NPM
NUSFT
7X8
5PM
TASJS
ID FETCH-LOGICAL-c519t-a22dc9f9d2d92699d948522a15c4a520a038d7233e6b765dec930188fa1ee9b53
IEDL.DBID 0YH
ISSN 0895-8378
1091-7691
IngestDate Thu Aug 21 18:09:29 EDT 2025
Fri Jul 11 16:21:31 EDT 2025
Thu Apr 03 07:09:56 EDT 2025
Thu Apr 24 23:03:20 EDT 2025
Tue Jul 01 02:24:45 EDT 2025
Wed Dec 25 09:07:44 EST 2024
Tue Jul 04 19:22:13 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 13
Keywords epidemiology
rock wool
refractory ceramic fiber
fiber dimensions
pleural plaques
mesothelioma
Biopersistence
Language English
License open-access: http://creativecommons.org/licenses/by/3.0: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
This is an open-access article distributed under the terms of the CC-BY-NC-ND 3.0 License which permits users to download and share the article for non-commercial purposes, so long as the article is reproduced in the whole without changes, and provided the original source is credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c519t-a22dc9f9d2d92699d948522a15c4a520a038d7233e6b765dec930188fa1ee9b53
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
Based in part on a talk presented at the International Conference “Advances and Controversies in Fibre Toxicology” at CMDC, Cranfield University, Cranfield, UK, 3–4 June 2014.
OpenAccessLink https://www.tandfonline.com/doi/abs/10.3109/08958378.2014.953276
PMID 25264933
PQID 1620023470
PQPubID 23479
PageCount 22
ParticipantIDs pubmed_primary_25264933
proquest_miscellaneous_1620023470
informahealthcare_journals_10_3109_08958378_2014_953276
crossref_primary_10_3109_08958378_2014_953276
informaworld_taylorfrancis_310_3109_08958378_2014_953276
crossref_citationtrail_10_3109_08958378_2014_953276
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4245174
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-11-01
PublicationDateYYYYMMDD 2014-11-01
PublicationDate_xml – month: 11
  year: 2014
  text: 2014-11-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Inhalation toxicology
PublicationTitleAlternate Inhal Toxicol
PublicationYear 2014
Publisher Informa Healthcare USA, Inc
Taylor & Francis
Publisher_xml – name: Informa Healthcare USA, Inc
– name: Taylor & Francis
References CIT0111
CIT0112
CIT0114
CIT0117
CIT0116
CIT0119
CIT0118
Letourneux M (CIT0113) 1999; 16
CIT0120
CIT0001
CIT0122
CIT0121
Davis JMG (CIT0055) 1986; 67
Warheit DB (CIT0191) 1994
Bolton RE (CIT0036) 1984; 2
Health Council of the Netherlands (DECOS) (CIT0083) 2010
CIT0124
CIT0005
CIT0126
CIT0004
CIT0125
CIT0007
CIT0128
CIT0127
CIT0009
Scientific Committee on Occupational Exposure Limits (SCOEL) (CIT0177) 2011
CIT0008
Desoubeaux N (CIT0058) 2001; 49
CIT0129
CIT0010
CIT0131
CIT0130
CIT0012
CIT0133
CIT0011
CIT0132
Thermal Insulation Manufacturers Association (TIMA) Nomenclature Committee (CIT0184) 1993
Environmental Resources Management (ERM) (CIT0066) 1995
Imperatori A (CIT0096) 2013; 5
International Agency for Research on Cancer (IARC) (CIT0098) 2002; 81
CIT0135
CIT0013
CIT0134
CIT0016
CIT0137
CIT0015
CIT0136
Agency for Toxic Substances and Disease Registry (ATSDR) (CIT0006) 2000
CIT0018
CIT0139
CIT0017
CIT0138
CIT0019
CIT0140
CIT0021
CIT0142
CIT0020
CIT0141
CIT0023
CIT0144
CIT0022
CIT0143
Rubin A-H (CIT0169) 1986; 10
Wong O (CIT0193) 1991; 48
Agence Française de Sécurité Sanitaire de l'Environment et du Travail (AFSSET) (CIT0003) 2007
Davis JM (CIT0054) 1988; 69
CIT0025
CIT0146
CIT0024
CIT0145
CIT0027
CIT0148
CIT0026
Gibbs GW (CIT0074) 1980; 30
CIT0147
CIT0029
CIT0028
Davis JMG (CIT0056) 1984; 2
Sandén Å (CIT0171) 1992; 5
Dement JM (CIT0057) 1990; 88
Browne K (CIT0041) 1983; 40
Robinson CF (CIT0165) 1982; 39
National Toxicology Program (NTP) (CIT0150) 2010
Federal Register (CIT0069) 2005; 70
Kauffer E (CIT0104) 2003; 47
Hwang C (CIT0093) 1983; 40
CIT0100
Eastes W (CIT0063) 1994; 20
Banks DE (CIT0014) 2011
CIT0109
CIT0102
CIT0101
CIT0103
CIT0106
CIT0105
CIT0108
CIT0107
Marsh G (CIT0123) 1996; 12
CIT0072
CIT0071
CIT0192
CIT0195
CIT0194
CIT0076
CIT0075
CIT0196
CIT0078
CIT0077
Cherrie J (CIT0048) 1986; 12
CIT0190
Hillerdal G (CIT0088) 2001
CIT0085
CIT0084
CIT0087
CIT0086
CIT0089
CIT0081
CIT0080
Walker AM (CIT0189) 2012; 24
CIT0094
Esman N (CIT0067) 1979; 40
CIT0097
CIT0099
Brown RC (CIT0040) 2005; 49
CIT0090
CIT0092
CIT0091
Lipworth L (CIT0115) 2009; 51
National Research Council (NRC) (CIT0149) 2000
Harber P (CIT0079) 1987; 29
CIT0030
CIT0151
CIT0032
CIT0153
CIT0031
CIT0034
CIT0155
CIT0033
CIT0154
CIT0157
CIT0035
CIT0156
CIT0038
Health Council of the Netherlands (DECOS) (CIT0082) 2011
CIT0159
CIT0037
CIT0158
CIT0160
CIT0162
CIT0161
CIT0043
CIT0164
CIT0042
CIT0045
CIT0166
CIT0044
Filiberti R (CIT0070) 2014; 86
CIT0047
CIT0168
CIT0046
CIT0167
CIT0049
Eastes W (CIT0064) 1996; 12
Newman LS (CIT0152) 1989
CIT0050
CIT0170
CIT0052
CIT0173
CIT0051
CIT0172
CIT0175
CIT0174
CIT0176
CIT0179
ACC (CIT0002) 2004
CIT0178
CIT0059
ILSI Working Group (CIT0095) 2005; 17
CIT0061
CIT0182
CIT0060
CIT0181
Reinhartz A (CIT0163) 2004
CIT0062
CIT0183
CIT0065
CIT0186
CIT0185
CIT0188
CIT0187
Lanphear BP (CIT0110) 1992; 7
Gevenois PA (CIT0073) 2006
CIT0180
CIT0068
18027165 - Crit Rev Toxicol. 2007;37(10):839-86
12708148 - J Occup Environ Med. 2003 Apr;45(4):440-50
16169910 - Occup Environ Med. 2005 Oct;62(10):665-9
8919265 - Exp Toxicol Pathol. 1996 Jan;48(1):3-12
11029264 - Regul Toxicol Pharmacol. 2000 Aug;32(1):14-21
8869346 - Thorax. 1996 Aug;51 Suppl 2:S9-15
9553658 - Ann Oncol. 1998 Feb;9(2):139-49
22584686 - Toxicol Sci. 2012 Aug;128(2):461-70
9794173 - Cancer Causes Control. 1998 Aug;9(4):411-6
2835925 - Ann Occup Hyg. 1987;31(4B):731-54
24401539 - Oncology. 2014;86(1):33-43
7882918 - Environ Health Perspect. 1994 Oct;102 Suppl 5:139-43
3045007 - Int Arch Occup Environ Health. 1988;60(6):389-93
10854503 - Occup Environ Med. 2000 Jul;57(7):488-94
2272328 - Environ Health Perspect. 1990 Aug;88:311-7
6614727 - Ann Occup Hyg. 1983;27(2):157-71
495442 - Am Ind Hyg Assoc J. 1979 Feb;40(2):108-17
10992539 - Thorax. 2000 Oct;55(10):860-3
15288528 - Mutat Res. 2004 Sep 3;553(1-2):5-9
954709 - Environ Res. 1976 Aug;12(1):59-74
9707503 - Toxicol Appl Pharmacol. 1998 Aug;151(2):262-75
22642290 - Inhal Toxicol. 2012 Jun;24(7):416-24
8804939 - Eur Respir J. 1996 Jun;9(6):1206-10
23776320 - Indian J Occup Environ Med. 2012 Sep;16(3):119-23
21742228 - Rev Mal Respir. 2011 Jun;28(6):e11-7
10590549 - Appl Occup Environ Hyg. 1999 Nov;14(11):759-67
10897848 - Rev Mal Respir. 1999 Dec;16(6 Pt 2):1270-7
3393849 - Scand J Work Environ Health. 1988 Jun;14(3):145-52
6295247 - Ann Occup Hyg. 1982;26(1-4):569-82
3812494 - Am J Ind Med. 1986;10(5-6):555-62
12074022 - Ann Occup Hyg. 2002 Mar;46(2):135-42
11846639 - Regul Toxicol Pharmacol. 2002 Feb;35(1):95-104
11570360 - Inhal Toxicol. 2001 Sep;13(9):755-72
23989951 - Br J Cancer. 2013 Oct 1;109(7):1965-73
21641383 - Am J Pathol. 2011 Jun;178(6):2587-600
14648356 - Inhal Toxicol. 2003 Dec;15(14):1387-419
20068227 - Am J Respir Cell Mol Biol. 2010 Feb;42(2):133-9
21539475 - Inhal Toxicol. 1995;7(4):469-502
11836664 - Semin Oncol. 2002 Feb;29(1):2-17
3026035 - Scand J Work Environ Health. 1986;12 Suppl 1:18-25
11563601 - Int Arch Occup Environ Health. 2001 Aug;74(6):383-95
23825744 - J Thorac Dis. 2013 Jun;5(3):205-6
9563743 - Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1226-33
21345360 - Regul Toxicol Pharmacol. 2011 Jun;60(1):84-92
16036750 - Inhal Toxicol. 2004 Oct-Nov;16(11-12):801-7
9115020 - Epidemiology. 1997 May;8(3):259-68
11341549 - Ind Health. 2001 Apr;39(2):183-5
6523093 - Scand J Work Environ Health. 1984 Oct;10(5):293-8
8742325 - Fundam Appl Toxicol. 1996 Feb;29(2):269-79
17634686 - Ind Health. 2007 Jun;45(3):379-87
21895596 - Med J Aust. 2011 Sep 5;195(5):271-4
11114786 - Inhal Toxicol. 2000 Dec;12(12):1141-72
21162719 - Diagn Pathol. 2010;5:81
20957726 - Am J Ind Med. 2010 Nov;53(11):1070-80
6307339 - Br J Ind Med. 1983 Aug;40(3):273-9
8666112 - Eur Respir J. 1995 Dec;8(12):2149-73
7757174 - Occup Environ Med. 1995 Feb;52(2):97-104
15090665 - Occup Environ Med. 2004 May;61(5):438-41
21173534 - Ind Health. 2011;49(2):166-72
1108627 - Am Ind Hyg Assoc J. 1975 Nov;36(11):811-9
10711399 - Drug Chem Toxicol. 2000 Feb;23(1):223-42
19730396 - J Occup Environ Med. 2009 Sep;51(9):1075-87
10380162 - Inhal Toxicol. 1999 Feb;11(2):111-30
7597255 - Risk Anal. 1995 Apr;15(2):181-95
15941656 - Respir Med. 2006 Jan;100(1):75-82
1772796 - Br J Ind Med. 1991 Dec;48(12):818-24
11341560 - Ind Health. 2001 Apr;39(2):65-74
11706147 - Occup Environ Med. 2001 Dec;58(12):800-10
91808 - Lancet. 1979 Nov 17;2(8151):1074
8912756 - Am J Respir Crit Care Med. 1996 Nov;154(5):1405-10
7239672 - IARC Sci Publ. 1980;(30):69-78
18686078 - Crit Rev Toxicol. 2008;38 Suppl 1:49-73
23101644 - Rev Mal Respir. 2012 Oct;29(8):1035-46
16586409 - Am J Ind Med. 2006 Jun;49(6):460-7
2848570 - Br J Exp Pathol. 1988 Oct;69(5):717-37
11407937 - Regul Toxicol Pharmacol. 2001 Jun;33(3):350-5
2839895 - Scand J Work Environ Health. 1988;14 Suppl 1:49-51
11350196 - Regul Toxicol Pharmacol. 2001 Apr;33(2):138-46
6299326 - Br J Ind Med. 1983 May;40(2):145-52
10905265 - Lancet. 2000 May 13;355(9216):1723-4
17099906 - Am J Ind Med. 2006 Dec;49(12):1066-9
7724842 - Regul Toxicol Pharmacol. 1994 Dec;20(3 Pt 2):S104-12
2872911 - Br J Exp Pathol. 1986 Jun;67(3):415-30
12724555 - Occup Med (Lond). 2003 May;53(3):209-12
4001900 - Scand J Work Environ Health. 1985 Apr;11(2):117-22
19749604 - J Occup Environ Med. 2009 Oct;51(10):1177-84
2167956 - J Occup Med. 1990 Jul;32(7):594-604
9400735 - Environ Health Perspect. 1997 Sep;105 Suppl 5:1261-3
7117223 - Environ Res. 1982 Aug;28(2):386-98
20737138 - Arch Toxicol. 2011 Mar;85(3):185-92
22796921 - J Occup Environ Med. 2012 Jul;54(7):781-8
18300048 - Inhal Toxicol. 2008 Feb;20(3):289-309
11696864 - Inhal Toxicol. 2001 Oct;13(10):851-75
8571091 - Scand J Work Environ Health. 1995 Oct;21(5):353-61
11341546 - Ind Health. 2001 Apr;39(2):161-7
16209704 - Part Fibre Toxicol. 2005 Oct 06;2:8
839555 - J Natl Cancer Inst. 1977 Mar;58(3):587-603
2306689 - Cancer. 1990 Mar 15;65(6):1449-55
21539476 - Inhal Toxicol. 1995;7(4):425-67
8543383 - Int Arch Occup Environ Health. 1995;67(5):343-6
17980576 - Eur J Cancer. 2007 Dec;43(18):2722-8
16040559 - Inhal Toxicol. 2005 Sep;17(10):497-537
2272321 - Environ Health Perspect. 1990 Aug;88:261-8
18096653 - Occup Environ Med. 2008 Sep;65(9):613-9
12475867 - Chest. 2002 Dec;122(6):2224-9
17455866 - Tumori. 2007 Jan-Feb;93(1):19-22
12855491 - Ann Occup Hyg. 2003 Jul;47(5):413-26
20798015 - Occup Environ Med. 2011 Feb;68(2):89-95
11845101 - Rev Epidemiol Sante Publique. 2001 Dec;49(6):523-9
12065376 - Chest. 2002 Jun;121(6):2044-51
7757162 - Occup Environ Med. 1995 Feb;52(2):105-9
16837114 - Regul Toxicol Pharmacol. 2006 Oct;46(1):42-62
10366897 - Ann Occup Hyg. 1999 Apr;43(3):155-66
15668258 - Ann Occup Hyg. 2005 Jun;49(4):295-307
24766058 - Crit Rev Toxicol. 2014 May;44(5):436-49
6095718 - Ann Occup Hyg. 1984;28(3):333-9
24649303 - Mol Clin Oncol. 2014 Jan;2(1):26-30
23287997 - BMJ. 2013;346:e8376
11696863 - Inhal Toxicol. 2001 Oct;13(10):823-49
7882917 - Environ Health Perspect. 1994 Oct;102 Suppl 5:133-7
22126592 - Cancer Sci. 2012 Mar;103(3):483-90
9227715 - Thorax. 1997 Jun;52(6):507-12
23121302 - Inhal Toxicol. 2012 Nov;24(13):928-9
12094100 - Epidemiology. 2002 Jul;13(4):445-53
20388033 - Inhal Toxicol. 2010 May;22(6):500-21
10968563 - Int Arch Occup Environ Health. 2000 Jun;73 Suppl:S60-8
8275791 - Chest. 1994 Jan;105(1):8-9
6279138 - Br J Ind Med. 1982 Feb;39(1):45-53
20386624 - Indian J Occup Environ Med. 2009 Aug;13(2):80-3
9356279 - Regul Toxicol Pharmacol. 1997 Oct;26(2):156-71
17053017 - Occup Environ Med. 2007 Aug;64(8):502-8
10880135 - Inhal Toxicol. 2000 May;12(5):359-99
1572439 - Eur Respir J. 1992 Mar;5(3):281-5
3436395 - Exp Pathol. 1987;32(3):129-52
9801022 - Am J Epidemiol. 1998 Nov 1;148(9):910-9
1494965 - J Occup Med. 1992 Jul;34(7):718-21
10450772 - Scand J Work Environ Health. 1999 Jun;25(3):222-6
24083862 - Am J Respir Crit Care Med. 2013 Oct 1;188(7):873
18236228 - Inhal Toxicol. 2008 Jan;20(2):139-47
8275722 - Chest. 1994 Jan;105(1):144-50
3655947 - J Occup Med. 1987 Aug;29(8):641-4
8742311 - Fundam Appl Toxicol. 1996 Feb;29(2):155-67
17717621 - Scand J Work Environ Health. 2007 Aug;33(4):286-92
12929149 - Am J Ind Med. 2003 Sep;44(3):291-7
15645436 - Int J Cancer. 2005 May 20;115(1):142-7
19001953 - J Occup Environ Med. 2008 Nov;50(11):1273-81
16221782 - N Engl J Med. 2005 Oct 13;353(15):1591-603
1415285 - Am J Ind Med. 1992;22(2):185-92
16814911 - Regul Toxicol Pharmacol. 2006 Aug;45(3):252-64
23471464 - Am J Respir Crit Care Med. 2013 May 1;187(9):977-82
1890486 - J Occup Med. 1991 Jul;33(7):770-3
14248731 - N Engl J Med. 1965 Mar 18;272:560-5
4377876 - Environ Health Perspect. 1974 Dec;9:313-5
References_xml – ident: CIT0052
  doi: 10.1136/oem.58.12.800
– volume: 48
  start-page: 818
  year: 1991
  ident: CIT0193
  publication-title: Br J Ind Med
– ident: CIT0034
  doi: 10.5271/sjweh.427
– ident: CIT0042
  doi: 10.1136/oem.52.2.105
– ident: CIT0128
  doi: 10.1080/08958370050198511
– ident: CIT0156
  doi: 10.1002/ajim.4700220205
– ident: CIT0181
  doi: 10.1093/jnci/58.3.587
– ident: CIT0160
  doi: 10.2307/3428305
– volume: 5
  start-page: 205
  year: 2013
  ident: CIT0096
  publication-title: J Thorac Dis
– ident: CIT0153
  doi: 10.1186/1743-8977-2-8
– ident: CIT0015
  doi: 10.1080/10408440802273156
– ident: CIT0147
  doi: 10.2307/3432074
– volume-title: Occupational asbestosis and related diseases. Medical/Scientific Update
  year: 1989
  ident: CIT0152
– ident: CIT0087
  doi: 10.1289/ehp.94102s5133
– ident: CIT0195
  doi: 10.1136/thx.52.6.507
– ident: CIT0001
  doi: 10.1164/ajrccm-conference.2011.183.1_MeetingAbstracts.A4812
– volume: 86
  start-page: 33
  year: 2014
  ident: CIT0070
  publication-title: A prospective study on Italian workers exposed to asbestos. Oncology
– ident: CIT0131
  doi: 10.1006/rtph.1997.1153
– ident: CIT0091
  doi: 10.1093/occmed/kqg051
– ident: CIT0044
  doi: 10.1053/sonc.2002.30227
– ident: CIT0118
  doi: 10.1164/ajrccm.157.4.9707131
– ident: CIT0062
  doi: 10.1136/bmj.e8376
– ident: CIT0133
  doi: 10.3109/08958379509015210
– ident: CIT0126
  doi: 10.3109/08958379509015209
– ident: CIT0008
  doi: 10.1016/j.rmr.2011.04.008
– volume: 51
  start-page: 1057
  year: 2009
  ident: CIT0115
  publication-title: JOEM
– ident: CIT0100
  doi: 10.1136/thx.51.Suppl_2.S9
– ident: CIT0132
  doi: 10.1006/rtph.2000.1409
– ident: CIT0134
  doi: 10.3109/08958379409003042
– ident: CIT0129
  doi: 10.1080/08958370701866040
– volume: 40
  start-page: 145
  year: 1983
  ident: CIT0041
  publication-title: Br J Ind Med
– volume: 10
  start-page: 555
  year: 1986
  ident: CIT0169
  publication-title: Am J Ind Health
– ident: CIT0023
– ident: CIT0037
  doi: 10.1093/annhyg/26.5.569
– volume: 49
  start-page: 523
  year: 2001
  ident: CIT0058
  publication-title: Rev Epidemiol Sante Publ
– ident: CIT0018
  doi: 10.1016/j.yrtph.2006.04.008
– volume: 40
  start-page: 106
  year: 1979
  ident: CIT0067
  publication-title: Am Ind Hyg Assoc J
– ident: CIT0068
  doi: 10.1016/0013-9351(82)90137-2
– ident: CIT0080
  doi: 10.1002/ajim.20844
– ident: CIT0012
  doi: 10.1002/ajim.20316
– ident: CIT0137
  doi: 10.1378/chest.122.6.2224
– volume: 16
  start-page: 1270
  year: 1999
  ident: CIT0113
  publication-title: Rev Mal Respir
– ident: CIT0140
  doi: 10.1006/rtph.2001.1474
– volume: 70
  start-page: 43950
  year: 2005
  ident: CIT0069
  publication-title: Asbestos Exposure Limit; Proposed Rule
– ident: CIT0108
  doi: 10.1080/08958370701821375
– ident: CIT0173
  doi: 10.1093/toxsci/kfs171
– ident: CIT0107
  doi: 10.1289/ehp.97105s51261
– volume-title: Presented at the USEPA 2001 Asbestos Health Effects Conference
  year: 2001
  ident: CIT0088
– ident: CIT0166
  doi: 10.1080/08958370490505016
– ident: CIT0179
  doi: 10.1378/chest.105.1.8
– ident: CIT0011
  doi: 10.1023/A:1008239116237
– ident: CIT0072
  doi: 10.1111/j.1349-7006.2011.02165.x
– ident: CIT0167
  doi: 10.1016/S0940-2993(96)80084-4
– ident: CIT0144
  doi: 10.1006/faat.1996.0017
– ident: CIT0060
  doi: 10.1002/ajim.10263
– volume: 7
  start-page: 718
  year: 1992
  ident: CIT0110
  publication-title: J Occup Med
– ident: CIT0175
  doi: 10.1093/annhyg/27.2.157
– ident: CIT0109
  doi: 10.1164/rccm.201210-1911OC
– ident: CIT0114
  doi: 10.1289/ehp.9088311
– volume: 47
  start-page: 413
  year: 2003
  ident: CIT0104
  publication-title: Ann Occup Hyg
– ident: CIT0185
  doi: 10.1136/oem.52.2.97
– ident: CIT0157
  doi: 10.1097/JOM.0b013e3181b68cef
– ident: CIT0117
  doi: 10.1378/chest.121.6.2044
– ident: CIT0106
  doi: 10.5271/sjweh.1957
– volume: 88
  start-page: 261
  year: 1990
  ident: CIT0057
  publication-title: Environ Health Perspect
– ident: CIT0030
  doi: 10.1177/030089160709300104
– volume: 12
  start-page: 381
  year: 1996
  ident: CIT0064
  publication-title: J Occup Health Safety Aust NZ
– ident: CIT0081
– volume-title: Refractory ceramic fibres, evaluation of the carcinogenicity and genotoxicity
  year: 2011
  ident: CIT0082
– ident: CIT0112
  doi: 10.1093/oxfordjournals.aje.a009717
– ident: CIT0045
  doi: 10.1136/oem.2006.027748
– ident: CIT0146
  doi: 10.1016/j.ajpath.2011.02.040
– start-page: 290
  volume-title: Saisine 2004/012 Rapport Final Relatif aux Fibres
  year: 2007
  ident: CIT0003
– ident: CIT0035
  doi: 10.1097/00001648-199705000-00006
– ident: CIT0178
  doi: 10.1056/NEJM196503182721104
– volume-title: Fact sheet on pleural plaques
  year: 2004
  ident: CIT0163
– ident: CIT0017
  doi: 10.1080/10408440701524592
– volume: 24
  start-page: 928
  year: 2012
  ident: CIT0189
  publication-title: Are airborne refractory ceramic fibers similar to asbestos in their carcinogenicity? Inhal Toxicol
– ident: CIT0136
  doi: 10.1136/oem.2009.048033
– ident: CIT0159
  doi: 10.5271/sjweh.49
– volume: 2
  start-page: 1028
  year: 1984
  ident: CIT0036
  publication-title: Proceedings of the 6th International Pneumonoconiosis Conference
– volume-title: Recommendation from the Scientific Committee on Occupational Exposure Limits for Refractory Ceramic fibres
  year: 2011
  ident: CIT0177
– volume-title: Draft Report on Carcinogens. Substance Profile for Glass Wool Fibers (Respirable) as a Class
  year: 2010
  ident: CIT0150
– ident: CIT0010
  doi: 10.1136/thorax.55.10.860
– volume-title: Review of the U.S. Navy's exposure standard for manufactured vitreous fibers, subcommittee on manufactured vitreous fibers, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission on Life Sciences, National Research Council
  year: 2000
  ident: CIT0149
– ident: CIT0065
  doi: 10.1007/BF00381385
– ident: CIT0105
  doi: 10.1097/00001648-200207000-00013
– ident: CIT0141
  doi: 10.1006/rtph.2000.1443
– volume: 81
  volume-title: Man-made vitreous fibres
  year: 2002
  ident: CIT0098
– ident: CIT0092
  doi: 10.3892/mco.2013.197
– ident: CIT0174
  doi: 10.5271/sjweh.2244
– ident: CIT0127
  doi: 10.1080/089583700196103
– ident: CIT0071
  doi: 10.1038/bjc.2013.514
– volume-title: Refractory Ceramic Fibers Coalition (RCFC)
  year: 1993
  ident: CIT0184
– ident: CIT0078
  doi: 10.2486/indhealth.MS1147
– ident: CIT0097
– ident: CIT0085
  doi: 10.1006/taap.1998.8472
– ident: CIT0089
  doi: 10.1177/1420326X9700600206
– ident: CIT0016
  doi: 10.1111/j.1539-6924.1995.tb00312.x
– ident: CIT0061
  doi: 10.1016/j.mrfmmm.2004.06.011
– ident: CIT0111
  doi: 10.1097/01.jom.0000052968.43131.b5
– volume: 2
  start-page: 303
  volume-title: Biological effects of man-made mineral fibers
  year: 1984
  ident: CIT0056
– ident: CIT0176
– ident: CIT0025
  doi: 10.3109/08958379609052913
– ident: CIT0031
  doi: 10.2486/indhealth.39.161
– volume: 17
  start-page: 497
  year: 2005
  ident: CIT0095
  publication-title: lnhal Toxicol
– ident: CIT0162
  doi: 10.1136/oem.2004.018531
– ident: CIT0142
  doi: 10.1081/DCT-100100112
– ident: CIT0026
  doi: 10.1080/089583799197203
– volume: 12
  start-page: 18
  year: 1986
  ident: CIT0048
  publication-title: Scand J Work Environ Health
– volume: 20
  start-page: S104
  year: 1994
  ident: CIT0063
  publication-title: Reg Toxicol Pharm
– ident: CIT0090
  doi: 10.1378/chest.105.1.144
– ident: CIT0013
  doi: 10.1136/oem.57.7.488
– ident: CIT0154
  doi: 10.1007/PL00014628
– ident: CIT0155
  doi: 10.5694/mja11.10125
– ident: CIT0094
  doi: 10.5271/sjweh.1145
– volume-title: Asbestos, risks of environmental and occupational exposure
  year: 2010
  ident: CIT0083
– ident: CIT0172
  doi: 10.1097/00043764-199107000-00008
– ident: CIT0043
  doi: 10.5094/APR.2012.020
– ident: CIT0050
  doi: 10.1023/A:1008871718323
– ident: CIT0119
  doi: 10.1164/ajrccm.154.5.8912756
– volume: 12
  start-page: 297
  year: 1996
  ident: CIT0123
  publication-title: J Occup Health Saf Aust NZ
– ident: CIT0084
  doi: 10.1165/rcmb.2009-0206TR
– ident: CIT0170
  doi: 10.1183/09031936.96.09061206
– volume-title: Asbestos toxicity physiologic effects
  year: 2000
  ident: CIT0006
– ident: CIT0032
  doi: 10.1186/1746-1596-5-81
– ident: CIT0122
  doi: 10.1016/j.yrtph.2011.02.009
– ident: CIT0007
  doi: 10.1016/j.rmr.2012.02.012
– ident: CIT0190
  doi: 10.1006/rtph.2001.1513
– ident: CIT0076
  doi: 10.1002/ajim.20394
– ident: CIT0033
  doi: 10.3109/10408444.2014.899558
– ident: CIT0120
  doi: 10.1016/j.ejca.2007.09.018
– volume: 49
  start-page: 295
  year: 2005
  ident: CIT0040
  publication-title: Ann Occup Hyg
– ident: CIT0101
  doi: 10.5271/sjweh.1938
– ident: CIT0102
  doi: 10.1093/annhyg/mef034
– ident: CIT0138
  doi: 10.1016/S0003-4878(99)00018-6
– ident: CIT0143
  doi: 10.2486/indhealth.39.65
– ident: CIT0028
  doi: 10.4103/0019-5278.55124
– ident: CIT0183
  doi: 10.2486/indhealth.39.183
– ident: CIT0051
  doi: 10.1016/0013-9351(76)90009-8
– start-page: 1352
  volume-title: Textbook of pulmonary and critical care medicine
  year: 2011
  ident: CIT0014
– ident: CIT0049
  doi: 10.1080/15298669391354612
– ident: CIT0027
  doi: 10.4103/0019-5278.111753
– ident: CIT0059
  doi: 10.1183/09031936.95.08122149
– ident: CIT0158
  doi: 10.1097/JOM.0b013e31818345bb
– ident: CIT0047
  doi: 10.1080/02786828608959100
– volume: 67
  start-page: 415
  year: 1986
  ident: CIT0055
  publication-title: Br J Exp Pathol
– volume: 39
  start-page: 45
  year: 1982
  ident: CIT0165
  publication-title: Br J Ind Med
– ident: CIT0086
  doi: 10.1006/faat.1996.0031
– ident: CIT0145
  doi: 10.5271/sjweh.2326
– ident: CIT0077
  doi: 10.1016/S0003-4878(98)00026-X
– ident: CIT0046
  doi: 10.1016/j.rmed.2005.04.017
– ident: CIT0186
  doi: 10.3109/08958370903521224
– ident: CIT0024
  doi: 10.1093/annhyg/41.inhaled_particles_VIII.224
– ident: CIT0021
  doi: 10.1080/089583701752378142
– ident: CIT0019
  doi: 10.1080/08958370390248888
– ident: CIT0099
  doi: 10.1007/BF00385650
– ident: CIT0125
  doi: 10.3109/08958379509015208
– ident: CIT0005
– ident: CIT0022
– ident: CIT0139
  doi: 10.1080/089583701316941294
– ident: CIT0182
  doi: 10.1136/oem.2007.035584
– ident: CIT0038
  doi: 10.1164/rccm.201304-0655LE
– volume: 69
  start-page: 717
  year: 1988
  ident: CIT0054
  publication-title: Br J Exp Pathol
– ident: CIT0164
  doi: 10.1056/NEJMra050152
– ident: CIT0151
  doi: 10.1007/s004200100240
– volume: 30
  start-page: 69
  volume-title: Biological effects of mineral fibers
  year: 1980
  ident: CIT0074
– ident: CIT0130
  doi: 10.1016/j.yrtph.2006.05.003
– volume: 29
  start-page: 641
  year: 1987
  ident: CIT0079
  publication-title: J Occup Med
– ident: CIT0192
  doi: 10.1136/oem.2003.010165
– ident: CIT0029
  doi: 10.2486/indhealth.45.379
– ident: CIT0103
  doi: 10.1002/1097-0142(19900315)65:6<1449::AID-CNCR2820650633>3.0.CO;2-0
– ident: CIT0004
– ident: CIT0009
  doi: 10.1080/0002889758507347
– ident: CIT0121
  doi: 10.1002/ijc.20820
– ident: CIT0161
  doi: 10.1016/S0232-1513(87)80044-0
– volume: 40
  start-page: 273
  year: 1983
  ident: CIT0093
  publication-title: Br J Ind Med
– ident: CIT0148
– volume-title: ACC Review: Asbestos-related disease
  year: 2004
  ident: CIT0002
– ident: CIT0196
  doi: 10.1080/104732299302189
– ident: CIT0116
  doi: 10.1097/JOM.0b013e31825296fd
– volume: 5
  start-page: 281
  year: 1992
  ident: CIT0171
  publication-title: Eur Respir J
  doi: 10.1183/09031936.93.05030281
– start-page: 253
  volume-title: Toxic and carcinogenic effects of solid particles in the respiratory tract
  year: 1994
  ident: CIT0191
– ident: CIT0135
  doi: 10.1016/S0140-6736(79)92468-1
– volume-title: Description and characterization of the ceramic fibres industry of the European Union
  year: 1995
  ident: CIT0066
– ident: CIT0187
  doi: 10.1080/15428119591016494
– ident: CIT0075
  doi: 10.1007/s00204-010-0580-2
– ident: CIT0188
  doi: 10.3109/08958378.2012.683892
– ident: CIT0194
  doi: 10.1016/S0140-6736(05)73126-3
– ident: CIT0020
  doi: 10.1080/089583701752378133
– ident: CIT0124
  doi: 10.1097/00043764-199007000-00009
– start-page: 315
  volume-title: Part of the medical radiology, diagnostic imaging and radiation oncology series
  year: 2006
  ident: CIT0073
– ident: CIT0180
  doi: 10.1093/annhyg/31.4B.731
– ident: CIT0168
  doi: 10.1093/annhyg/28.3.333
– reference: 18096653 - Occup Environ Med. 2008 Sep;65(9):613-9
– reference: 7239672 - IARC Sci Publ. 1980;(30):69-78
– reference: 21162719 - Diagn Pathol. 2010;5:81
– reference: 9115020 - Epidemiology. 1997 May;8(3):259-68
– reference: 17455866 - Tumori. 2007 Jan-Feb;93(1):19-22
– reference: 8742311 - Fundam Appl Toxicol. 1996 Feb;29(2):155-67
– reference: 18027165 - Crit Rev Toxicol. 2007;37(10):839-86
– reference: 23989951 - Br J Cancer. 2013 Oct 1;109(7):1965-73
– reference: 10880135 - Inhal Toxicol. 2000 May;12(5):359-99
– reference: 10366897 - Ann Occup Hyg. 1999 Apr;43(3):155-66
– reference: 8919265 - Exp Toxicol Pathol. 1996 Jan;48(1):3-12
– reference: 10590549 - Appl Occup Environ Hyg. 1999 Nov;14(11):759-67
– reference: 24083862 - Am J Respir Crit Care Med. 2013 Oct 1;188(7):873
– reference: 17634686 - Ind Health. 2007 Jun;45(3):379-87
– reference: 15090665 - Occup Environ Med. 2004 May;61(5):438-41
– reference: 3812494 - Am J Ind Med. 1986;10(5-6):555-62
– reference: 8912756 - Am J Respir Crit Care Med. 1996 Nov;154(5):1405-10
– reference: 12724555 - Occup Med (Lond). 2003 May;53(3):209-12
– reference: 12475867 - Chest. 2002 Dec;122(6):2224-9
– reference: 23121302 - Inhal Toxicol. 2012 Nov;24(13):928-9
– reference: 3026035 - Scand J Work Environ Health. 1986;12 Suppl 1:18-25
– reference: 91808 - Lancet. 1979 Nov 17;2(8151):1074
– reference: 8869346 - Thorax. 1996 Aug;51 Suppl 2:S9-15
– reference: 22584686 - Toxicol Sci. 2012 Aug;128(2):461-70
– reference: 10968563 - Int Arch Occup Environ Health. 2000 Jun;73 Suppl:S60-8
– reference: 20068227 - Am J Respir Cell Mol Biol. 2010 Feb;42(2):133-9
– reference: 23287997 - BMJ. 2013;346:e8376
– reference: 16837114 - Regul Toxicol Pharmacol. 2006 Oct;46(1):42-62
– reference: 17099906 - Am J Ind Med. 2006 Dec;49(12):1066-9
– reference: 15645436 - Int J Cancer. 2005 May 20;115(1):142-7
– reference: 21539475 - Inhal Toxicol. 1995;7(4):469-502
– reference: 21345360 - Regul Toxicol Pharmacol. 2011 Jun;60(1):84-92
– reference: 2167956 - J Occup Med. 1990 Jul;32(7):594-604
– reference: 6307339 - Br J Ind Med. 1983 Aug;40(3):273-9
– reference: 8543383 - Int Arch Occup Environ Health. 1995;67(5):343-6
– reference: 20388033 - Inhal Toxicol. 2010 May;22(6):500-21
– reference: 7757174 - Occup Environ Med. 1995 Feb;52(2):97-104
– reference: 16221782 - N Engl J Med. 2005 Oct 13;353(15):1591-603
– reference: 12929149 - Am J Ind Med. 2003 Sep;44(3):291-7
– reference: 2835925 - Ann Occup Hyg. 1987;31(4B):731-54
– reference: 24649303 - Mol Clin Oncol. 2014 Jan;2(1):26-30
– reference: 7724842 - Regul Toxicol Pharmacol. 1994 Dec;20(3 Pt 2):S104-12
– reference: 19730396 - J Occup Environ Med. 2009 Sep;51(9):1075-87
– reference: 8275791 - Chest. 1994 Jan;105(1):8-9
– reference: 21641383 - Am J Pathol. 2011 Jun;178(6):2587-600
– reference: 14648356 - Inhal Toxicol. 2003 Dec;15(14):1387-419
– reference: 22642290 - Inhal Toxicol. 2012 Jun;24(7):416-24
– reference: 16169910 - Occup Environ Med. 2005 Oct;62(10):665-9
– reference: 11563601 - Int Arch Occup Environ Health. 2001 Aug;74(6):383-95
– reference: 3393849 - Scand J Work Environ Health. 1988 Jun;14(3):145-52
– reference: 17053017 - Occup Environ Med. 2007 Aug;64(8):502-8
– reference: 15288528 - Mutat Res. 2004 Sep 3;553(1-2):5-9
– reference: 23471464 - Am J Respir Crit Care Med. 2013 May 1;187(9):977-82
– reference: 11706147 - Occup Environ Med. 2001 Dec;58(12):800-10
– reference: 19749604 - J Occup Environ Med. 2009 Oct;51(10):1177-84
– reference: 11836664 - Semin Oncol. 2002 Feb;29(1):2-17
– reference: 10854503 - Occup Environ Med. 2000 Jul;57(7):488-94
– reference: 11341546 - Ind Health. 2001 Apr;39(2):161-7
– reference: 19001953 - J Occup Environ Med. 2008 Nov;50(11):1273-81
– reference: 21539476 - Inhal Toxicol. 1995;7(4):425-67
– reference: 10992539 - Thorax. 2000 Oct;55(10):860-3
– reference: 11341560 - Ind Health. 2001 Apr;39(2):65-74
– reference: 11407937 - Regul Toxicol Pharmacol. 2001 Jun;33(3):350-5
– reference: 9707503 - Toxicol Appl Pharmacol. 1998 Aug;151(2):262-75
– reference: 16586409 - Am J Ind Med. 2006 Jun;49(6):460-7
– reference: 12065376 - Chest. 2002 Jun;121(6):2044-51
– reference: 6523093 - Scand J Work Environ Health. 1984 Oct;10(5):293-8
– reference: 495442 - Am Ind Hyg Assoc J. 1979 Feb;40(2):108-17
– reference: 23776320 - Indian J Occup Environ Med. 2012 Sep;16(3):119-23
– reference: 8571091 - Scand J Work Environ Health. 1995 Oct;21(5):353-61
– reference: 8666112 - Eur Respir J. 1995 Dec;8(12):2149-73
– reference: 16814911 - Regul Toxicol Pharmacol. 2006 Aug;45(3):252-64
– reference: 24766058 - Crit Rev Toxicol. 2014 May;44(5):436-49
– reference: 20957726 - Am J Ind Med. 2010 Nov;53(11):1070-80
– reference: 1108627 - Am Ind Hyg Assoc J. 1975 Nov;36(11):811-9
– reference: 10905265 - Lancet. 2000 May 13;355(9216):1723-4
– reference: 1772796 - Br J Ind Med. 1991 Dec;48(12):818-24
– reference: 7597255 - Risk Anal. 1995 Apr;15(2):181-95
– reference: 21742228 - Rev Mal Respir. 2011 Jun;28(6):e11-7
– reference: 11114786 - Inhal Toxicol. 2000 Dec;12(12):1141-72
– reference: 11570360 - Inhal Toxicol. 2001 Sep;13(9):755-72
– reference: 6299326 - Br J Ind Med. 1983 May;40(2):145-52
– reference: 10450772 - Scand J Work Environ Health. 1999 Jun;25(3):222-6
– reference: 12074022 - Ann Occup Hyg. 2002 Mar;46(2):135-42
– reference: 2839895 - Scand J Work Environ Health. 1988;14 Suppl 1:49-51
– reference: 20798015 - Occup Environ Med. 2011 Feb;68(2):89-95
– reference: 15941656 - Respir Med. 2006 Jan;100(1):75-82
– reference: 8275722 - Chest. 1994 Jan;105(1):144-50
– reference: 17980576 - Eur J Cancer. 2007 Dec;43(18):2722-8
– reference: 18300048 - Inhal Toxicol. 2008 Feb;20(3):289-309
– reference: 6095718 - Ann Occup Hyg. 1984;28(3):333-9
– reference: 12094100 - Epidemiology. 2002 Jul;13(4):445-53
– reference: 14248731 - N Engl J Med. 1965 Mar 18;272:560-5
– reference: 7757162 - Occup Environ Med. 1995 Feb;52(2):105-9
– reference: 2272328 - Environ Health Perspect. 1990 Aug;88:311-7
– reference: 20386624 - Indian J Occup Environ Med. 2009 Aug;13(2):80-3
– reference: 9801022 - Am J Epidemiol. 1998 Nov 1;148(9):910-9
– reference: 11341549 - Ind Health. 2001 Apr;39(2):183-5
– reference: 12708148 - J Occup Environ Med. 2003 Apr;45(4):440-50
– reference: 11029264 - Regul Toxicol Pharmacol. 2000 Aug;32(1):14-21
– reference: 11845101 - Rev Epidemiol Sante Publique. 2001 Dec;49(6):523-9
– reference: 11696864 - Inhal Toxicol. 2001 Oct;13(10):851-75
– reference: 8742325 - Fundam Appl Toxicol. 1996 Feb;29(2):269-79
– reference: 16209704 - Part Fibre Toxicol. 2005 Oct 06;2:8
– reference: 18686078 - Crit Rev Toxicol. 2008;38 Suppl 1:49-73
– reference: 3655947 - J Occup Med. 1987 Aug;29(8):641-4
– reference: 954709 - Environ Res. 1976 Aug;12(1):59-74
– reference: 21173534 - Ind Health. 2011;49(2):166-72
– reference: 9356279 - Regul Toxicol Pharmacol. 1997 Oct;26(2):156-71
– reference: 839555 - J Natl Cancer Inst. 1977 Mar;58(3):587-603
– reference: 4001900 - Scand J Work Environ Health. 1985 Apr;11(2):117-22
– reference: 4377876 - Environ Health Perspect. 1974 Dec;9:313-5
– reference: 9227715 - Thorax. 1997 Jun;52(6):507-12
– reference: 9794173 - Cancer Causes Control. 1998 Aug;9(4):411-6
– reference: 23825744 - J Thorac Dis. 2013 Jun;5(3):205-6
– reference: 24401539 - Oncology. 2014;86(1):33-43
– reference: 7117223 - Environ Res. 1982 Aug;28(2):386-98
– reference: 10711399 - Drug Chem Toxicol. 2000 Feb;23(1):223-42
– reference: 2848570 - Br J Exp Pathol. 1988 Oct;69(5):717-37
– reference: 1415285 - Am J Ind Med. 1992;22(2):185-92
– reference: 10897848 - Rev Mal Respir. 1999 Dec;16(6 Pt 2):1270-7
– reference: 11846639 - Regul Toxicol Pharmacol. 2002 Feb;35(1):95-104
– reference: 1572439 - Eur Respir J. 1992 Mar;5(3):281-5
– reference: 11350196 - Regul Toxicol Pharmacol. 2001 Apr;33(2):138-46
– reference: 2272321 - Environ Health Perspect. 1990 Aug;88:261-8
– reference: 18236228 - Inhal Toxicol. 2008 Jan;20(2):139-47
– reference: 11696863 - Inhal Toxicol. 2001 Oct;13(10):823-49
– reference: 23101644 - Rev Mal Respir. 2012 Oct;29(8):1035-46
– reference: 9553658 - Ann Oncol. 1998 Feb;9(2):139-49
– reference: 7882917 - Environ Health Perspect. 1994 Oct;102 Suppl 5:133-7
– reference: 3045007 - Int Arch Occup Environ Health. 1988;60(6):389-93
– reference: 21895596 - Med J Aust. 2011 Sep 5;195(5):271-4
– reference: 2872911 - Br J Exp Pathol. 1986 Jun;67(3):415-30
– reference: 12855491 - Ann Occup Hyg. 2003 Jul;47(5):413-26
– reference: 16040559 - Inhal Toxicol. 2005 Sep;17(10):497-537
– reference: 6295247 - Ann Occup Hyg. 1982;26(1-4):569-82
– reference: 22796921 - J Occup Environ Med. 2012 Jul;54(7):781-8
– reference: 10380162 - Inhal Toxicol. 1999 Feb;11(2):111-30
– reference: 15668258 - Ann Occup Hyg. 2005 Jun;49(4):295-307
– reference: 17717621 - Scand J Work Environ Health. 2007 Aug;33(4):286-92
– reference: 1494965 - J Occup Med. 1992 Jul;34(7):718-21
– reference: 9563743 - Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1226-33
– reference: 3436395 - Exp Pathol. 1987;32(3):129-52
– reference: 2306689 - Cancer. 1990 Mar 15;65(6):1449-55
– reference: 16036750 - Inhal Toxicol. 2004 Oct-Nov;16(11-12):801-7
– reference: 1890486 - J Occup Med. 1991 Jul;33(7):770-3
– reference: 9400735 - Environ Health Perspect. 1997 Sep;105 Suppl 5:1261-3
– reference: 8804939 - Eur Respir J. 1996 Jun;9(6):1206-10
– reference: 7882918 - Environ Health Perspect. 1994 Oct;102 Suppl 5:139-43
– reference: 6279138 - Br J Ind Med. 1982 Feb;39(1):45-53
– reference: 6614727 - Ann Occup Hyg. 1983;27(2):157-71
– reference: 22126592 - Cancer Sci. 2012 Mar;103(3):483-90
– reference: 20737138 - Arch Toxicol. 2011 Mar;85(3):185-92
SSID ssj0006037
Score 2.196499
SecondaryResourceType review_article
Snippet Abstract In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant...
In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a practical threshold. Inflammation was considered the predominant...
SourceID pubmedcentral
proquest
pubmed
crossref
informaworld
informahealthcare
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 789
SubjectTerms Animals
Biopersistence
Carcinogens - toxicity
Ceramics - toxicity
epidemiology
fiber dimensions
Humans
Inhalation Exposure - adverse effects
Kaolin - toxicity
Lung Neoplasms - chemically induced
mesothelioma
Mineral Fibers - toxicity
pleural plaques
Rats
refractory ceramic fiber
Review
rock wool
Title Perspectives on refractory ceramic fiber (RCF) carcinogenicity: comparisons with other fibers
URI https://www.tandfonline.com/doi/abs/10.3109/08958378.2014.953276
https://www.ncbi.nlm.nih.gov/pubmed/25264933
https://www.proquest.com/docview/1620023470
https://pubmed.ncbi.nlm.nih.gov/PMC4245174
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED629mUwStv9aNq1aDDKBtXqSJZt7a3tFsJgI4wWuodhZEmmhdYpdfqQ_753luMk3Y_CHo11tsx3sk7Sfd8BvCtKSXW5U47oJjwWJuU6sX1OLNBYSY8zCHGHv31Phmfx13N1vsDip7RKWkOXQSii-VfT4DZFU4GEdCwPo0wr0kGnxKz4o1b4quQprApyVvTo6Oew-xcnUVDNRAtOJoE899enLE1O66106UWXiPVAzvRPQenD3MqFyWqwDmttlMmOgltswBNfbcL-KMhUTw_Y6Zx1VR-wfTaaC1hPN-F52MtjgaL0An6N5ozMmo0rhh2_ber0TJnFB11j25IyT9j7HyeDD8xSfaJqjK55aTHI_8RsV-ywZrTxyxraV7CpX8LZ4MvpyZC3ZRm4xXBvwo0QzupSO-G0SLR2JDAjhOkrGxslIhPJzKVCItBFmijnrUZgsqw0fe91oeQrWKnGld8Chgvk2DhT6rLwceqdTvvWGWmM8MYrWfRAzvDIbatZTqUzrnJcuxCK-QzFnFDMA4o94J3VTdDseKR9-hvUeTuU60css0WHyCfNLksZSqKQ2b9M386cJ8cRTcc0pvLjO3xhQokzMk6jHrwOztR9hlAYwGopsctLbtY1ILXw5TvV5UWjGk5H3Lj83P7_Lu_AM7oKTMw3sDK5vfO7GJJNir1m1O3B6tHx5-PBPWOJLPI
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSxwxEA-tPrRQitpWr9U2gkgLRneTze7GN5EeV784ygntQwnZJItCu1fc8-H--85s9vY8-yH0eTNJlt8kmUlmfkPITlEKrMudMUA3ZQk3GVOpjRlmgSZSeDhBMHf4_CIdXCYnX-QsmrBuwyrRhy4DUUSzV-Pixsvog8bFjNRBlCuJROgYmZXsKwljpY_JsoSzF6s3RF8H3WacRoE2EyQYioTsub_2snA6rbTcpVddJNY9PtM_WaX3gyvvnFb9FfK8NTPpUdCLVfLIV2tkdxh4qqd7dDRPu6r36C4dzhmsp2vkWbjMoyFH6QX5NpynZNZ0XFGY-E1TqGdKLXT0A9qWGHpC338-7n-gFgsUVWPQzWsLVv4htV21w5rizS9t8r6CTP2SXPY_jo4HrK3LwCzYexNmOHdWlcpxp3iqlEOGGc5NLG1iJI9MJHKXcQFIF1kqnbeAS5znpYm9V4UUr8hSNa78BqHgISfGmVKVhU8y71QWW2eEMdwbL0XRI2KGh7YtaTnWzviuwXlBFPUMRY0o6oBij7BO6mcg7XigffYb1Lpdy_UDkvldhdCT5pqlDDVRUOxfotsz5dGwpPGdxlR-fAsDphg5I5Is6pH1oEzdb3AJFqwSAqa8oGZdA6QLX_xSXV81tOH4xg3-5-v_n_I78mQwOj_TZ58uTt-Qp_glpGVukqXJza3fAvtsUrxtVuAvQacu9A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rSxwxEA9WoRRKUfu6PiMUacHUvWSzu-m3oj1O28pRFOyHErJ5oNDuiXt-uP--M5u9vTv7EPy8mSTLTJKZZH6_IeRNGQTW5c4ZaDdjKTc5U5ntM0SBplJ4OEEQO_z1KBuepIen8nQBxY9plRhDh0gU0ezVuLgvXNhtIsxE7SaFksiDjolZ6XslYajsDlmTBRz1YNHJ92G3F2dJZM0ECYYiETz3z16WDqf1lrr0rEvEukZn-jen9Hpu5cJhNVgnD1ovk36MZrFBVny1SbZHkaZ6ukOP56ireodu09GcwHq6Se7HuzwaIUoPyY_RHJFZ03FFYeKXTZ2eKbXQ0S9oGzDzhL79tjd4Ry3WJ6rGYJrnFpz8D9R2xQ5rihe_tIF9RZn6ETkZfDreG7K2LAOz4O5NmOHcWRWU407xTCmHBDOcm760qZE8MYkoXM4FKLrMM-m8VbCLFEUwfe9VKcVjslqNK_-UUAiQU-NMUKH0ae6dyvvWGWEM98ZLUfaImOlD25azHEtn_NQQu6AW9UyLGrWooxZ7hHVSF5Gz44b2-R-q1u1Srm-QLBYNQk-aW5YQS6Kg2P9Et2bGo2FF4zONqfz4CgbMMHFGpHnSI0-iMXW_wSU4sEoImPKSmXUNkC18-Ut1ftawhuMTN4Sfz24_5dfk7mh_oL8cHH1-Tu7hhwjKfEFWJ5dX_iV4Z5PyVbMAfwNP4C4m
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Perspectives+on+refractory+ceramic+fiber+%28RCF%29+carcinogenicity%3A+comparisons+with+other+fibers&rft.jtitle=Inhalation+toxicology&rft.au=Greim%2C+Helmut&rft.au=Utell%2C+Mark+J.&rft.au=Maxim%2C+L.+Daniel&rft.au=Niebo%2C+Ron&rft.date=2014-11-01&rft.pub=Informa+Healthcare+USA%2C+Inc&rft.issn=0895-8378&rft.eissn=1091-7691&rft.volume=26&rft.issue=13&rft.spage=789&rft.epage=810&rft_id=info:doi/10.3109%2F08958378.2014.953276&rft.externalDocID=10_3109_08958378_2014_953276
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0895-8378&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0895-8378&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0895-8378&client=summon